Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The American Academy of Ophthalmology recommendations on screening for chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ophthalmology

Title: Ophthalmology

ISSN (Electronic): 1549-4713

ISSN (Print): 0161-6420

Publication date (Electronic): Jun 2016

Volume: 123

Issue: 6

Affiliations

[1 ] Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California.

[2 ] Zentrum für Seltene Netzhauterkrankungen, AugenZentrum Siegburg, Siegburg, Germany.

[3 ] Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong.

[4 ] Department of Ophthalmology, Kaiser Permanente, Redwood City Medical Center, Redwood City, California.

[5 ] Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago, Illinois.

Article

Publisher Item ID: S0161-6420(16)00201-3

DOI: 10.1016/j.ophtha.2016.01.058

PubMed ID: 26992838

SO-VID: 070903e8-54ff-4088-9483-c3ae7b20995b

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.